Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing. | Nat Commun | 2022 | 35241646 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of genomic alterations in acral melanoma. | Pigment Cell Melanoma Res | 2022 | 35229492 | PubTator, text mining | PubMed |
| MutSα expression predicts a lower disease-free survival in malignant salivary gland tumors: an immunohistochemical study. | Med Oral Patol Oral Cir Bucal | 2022 | 35218645 | PubTator, text mining | PubMed |
| Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer. | Dis Markers | 2022 | 35211210 | PubTator, text mining | PubMed |
| Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells. | Cancers (Basel) | 2022 | 35205738 | PubTator, text mining | PubMed |
| Myotonic Dystrophies: A Genetic Overview. | Genes (Basel) | 2022 | 35205411 | PubTator, text mining | PubMed |
| PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers. | Biomedicines | 2022 | 35203508 | PubTator, text mining | PubMed |
| Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes. | Biomedicines | 2022 | 35203410 | PubTator, text mining | PubMed |
| PMS2 variant results in loss of ATPase activity without compromising mismatch repair. | Mol Genet Genomic Med | 2022 | 35189042 | PubTator, text mining | PubMed |
| SLX4 dampens MutSα-dependent mismatch repair. | Nucleic Acids Res | 2022 | 35166826 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identifies a Novel Germline Variant in PTK7 Gene in Familial Colorectal Cancer. | Int J Mol Sci | 2022 | 35163215 | PubTator, text mining | PubMed |
| An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. | Int J Mol Sci | 2022 | 35163157 | PubTator, text mining | PubMed |
| CNOT6: A Novel Regulator of DNA Mismatch Repair. | Cells | 2022 | 35159331 | PubTator, text mining | PubMed |
| Potential Involvement of NSD1, KRT24 and ACACA in the Genetic Predisposition to Colorectal Cancer. | Cancers (Basel) | 2022 | 35158968 | PubTator, text mining | PubMed |
| Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors. | Cancers (Basel) | 2022 | 35158962 | PubTator, text mining | PubMed |
| Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer. | Cancers (Basel) | 2022 | 35158942 | PubTator, text mining | PubMed |
| Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair. | Nat Commun | 2022 | 35140211 | PubTator, text mining | PubMed |
| Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system. | Mol Biomed | 2022 | 35122182 | PubTator, text mining | PubMed |
| Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer. | J Immunother Cancer | 2022 | 35101943 | PubTator, text mining | PubMed |
| Elevated microsatellite instability at selected tetranucleotide (EMAST) repeats in gastric cancer: a distinct microsatellite instability type with potential clinical impact? | J Pathol Clin Res | 2022 | 35099128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=37